The vaccine doses AstraZeneca found in the Catalent factory in Agnani, 29 million in total, will be destined forEuropean Union. This is what the president of the EU Commission said, Ursula Von der Leyen, who thus reassured the Prime Minister Mario Draghi during the working session of the European Council on Covid-19. To Draghi, who retraced the salient points of the affair and asked the president if she thinks it is right that the doses of vaccines located in Belgium and the Netherlands remain destined for the European Union, in whole or in part, Von der Leyen replied that all doses produced in the EU they will be addressed to the Member States. During the press conference at the end of the meeting, von der Leyen however clarified that “of the 29 million doses, 13 million are for Covax and 16 million are for European Member States” and “it is important for us that the vaccines are delivered. to Covax which is the main pillar to make sure low-income countries have access to vaccines. “
During his speech, Draghi allegedly stated that “European citizens have the feeling that they have been deceived by some pharmaceutical companies, I am thinking above all of AstraZeneca “, asking that” a framework for fiscal policy that is able to take us out of the crisis “be drawn. The Prime Minister, therefore, did not mince words to refer to the Anglo-Swedish pharmaceutical giant , of which he also told what happened in the past few days in the Catalent plant in Agnani, in the province of Frosinone.
In the cold rooms of Anagni, as reported by the Nas, sent by Minister Speranza at the request of Draghi himself, pushed in turn at the personal suggestion of the president of the EU Commission, there are 29 million doses of AstraZeneca; instead of that of Johnson & Johnson none because, pending authorizations, the raw material has not arrived. In fact, the Catalent plant had been working slowly until last month, because even AstraZeneca’s raw material was slow to arrive after the problems encountered in the cell cultures of one of its plants in Belgium, in Puurs. And all this while continuing the dose cut that AstraZeneca itself should send to the EU: so far the company has delivered only 18 million doses of the vaccine to Brussels, compared to 30 million expected. They report it toAGI sources of the European Union. “We hope AstraZeneca has enough doses, whether they are in Anagni or elsewhere, to deliver the 12 million doses left to reach 30 million doses by the end of the month,” the source explained.
–
